MM

Madar Mohammad

Director Director DIN 07974217
DIN 07974217 First appointment Dec 2017
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Dec 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Madar Mohammad

Data last updated:

Madar Mohammad was a Director at Mleo Life Sciences Private Limited (2024) and Director at Erwin Life Sciences Private Limited (from 2017).

DIN 07974217
Primary Designation Director
First Appointment 27 Dec 2017
Oldest Company Age 8 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mleo Life Sciences Private Limited U46497TS2024PTC180950
Director11 Jan 20242024Active
Erwin Life Sciences Private Limited U51909TG2017PTC120911
Director27 Dec 20172017Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Erwin Life Sciences Private Limited
Mleo Life Sciences Private Limited
Premium access

Shareholding and investment profile for Madar Mohammad

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Madar Mohammad

Madar Mohammad was first appointed on 27 Dec 2017 as Director at Erwin Life Sciences Private Limited. The most recent appointment on record is 11 Jan 2024 at Mleo Life Sciences Private Limited.

Madar Mohammad held 2 earlier board appointments: Mleo Life Sciences Private Limited (Director, 11 Jan 2024 to 31 Dec 2024); Erwin Life Sciences Private Limited (Director, from 27 Dec 2017).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available